Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - APAC

APAC

In the year 2024, the revenue in the Digestives & Intestinal Remedies market market in the APAC region is projected to reach a substantial amount of US$8.32bn.
It is estimated that the market will experience an annual growth rate of 2.71% from 2024 to 2028, according to the compound annual growth rate (CAGR).
When compared to other countries globally, in China stands out as the top revenue generator in the Digestives & Intestinal Remedies market market, with a predicted revenue of US$4,408.00m in 2024.
This highlights in China's dominant position in this market within the APAC region.
To put this revenue into perspective, the per capita revenue generated in the Digestives & Intestinal Remedies market market is approximately US$1.94 per person in 2024.
This figure indicates the average revenue generated per individual based on the total population figures in the APAC region.
In China, the Digestives & Intestinal Remedies market is experiencing a surge in demand due to the increasing prevalence of gastrointestinal disorders.

Key regions: Canada, United States, Australia, Brazil, Japan

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.